MUMBAI, India, Sept. 22 -- Intellectual Property India has published a patent application (202641110012 A) filed by Nitte Deemed To Be University; Dr. Marina Koland; Mr. Karthik A S; and Dr. Pisay Muralidhar on September 14, 2026, for Controlled Release Transdermal Composition For Management Of Rheumatoid Arthritis.
Inventors include Dr. Marina Koland; Mr. Karthik A S; and Dr. Pisay Muralidhar.
The application for the patent was published on September 18, 2026, under issue no. 38/2026.
Abstract: ABSTRACT Disclosed herein is a controlled release transdermal composition (100) for management of rheumatoid arthritis, the composition (100) comprises a therapeutic agent (102) to suppress inflammatory pathways associated with rheumatoid arthritis, an amphiphilic lipid (104) to form a cubosomal nanocarrier for encapsulation and transdermal delivery of the therapeutic agent (102), an aqueous medium (106) to hydrate the amphiphilic lipid (104) and a biocompatible polymeric coating material (108) to regulate diffusion of the therapeutic agent (102), improve physicochemical stability, reduce burst release, enhance dermal retention and prolong systemic delivery of the therapeutic agent (102).
Disclaimer: Curated by HT Syndication.
